特征冲动性作为帕金森病治疗和进展的特征
Holly Spencer1, Ryan S Anderton1
1School of Health Sciences, University of Notre Dame Australia, Fremantle, WA, Australia.
Parkinson's disease
|May 20, 2024
概括
冲动性和冲动控制障碍 (ICD) 在帕金森病 (PD) 中越来越多地被认可. 多巴胺疗法可以触发这些行为,影响生活质量,需要更好的诊断和治疗.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 精神病学是一个精神病学.
背景情况:
- 特征冲动性,包括亚临床和病理形式,在帕金森病 (PD) 中越来越多地被认可.
- 在PD中,冲动控制障碍 (ICD) 源于奖励通路的干扰,导致重复性,过度和不适应性行为,如过度性行为,博,强迫性购物和暴饮暴食.
- 这些行为显著影响了PD患者及其照顾者的财务和社会地位,给生活质量带来负担.
研究的目的:
- 审查帕金森病中冲动性的特征,神经解剖学和神经化学.
- 检查现有的研究对导致PD冲动性的因素.
- 突出冲动性作为PD的重要非运动症状,并强调需要诊断和治疗的进步.
主要方法:
- 文献综述侧重于冲动性,神经解剖学,神经化学以及帕金森病的促成因素.
- 讨论ICD在PD中的临床表现和影响.
- 分析多巴胺替代疗法的作用,特别是多巴胺激动剂,在导致ICD的过程中.
主要成果:
- 增强的特征冲动性是帕金森病中普遍存在的非运动性症状,通常表现为ICD.
- 多巴胺激动剂治疗经常与PD患者的ICD发展有关.
- 在PD中冲动性显著影响患者和护理人员的生活质量,尽管它比运动症状少被认可.
结论:
- 冲动性是帕金森病的一个显著和有害的症状,需要更多的临床关注.
- 迫切需要开发有效的诊断工具和治疗策略,以管理PD中的冲动性和ICD.
- 对神经生物学基础和PD冲动性风险因素的进一步研究至关重要.
相关概念视频
01:24Parkinson's Disease: Treatment
261
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
261
01:15Parkinson's Disease: Overview
528
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
528
01:26Psychosis: Goals of Pharmacotherapy
123
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
123
01:28Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
01:22Alzheimer's Disease: Treatment
180
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
180
01:30Attention-Deficit/Hyperactivity Disorder
55
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
55